Market revenue in 2020 | USD 7.0 million |
Market revenue in 2027 | USD 10.8 million |
Growth rate | 6.4% (CAGR from 2020 to 2027) |
Largest segment | Detergents |
Fastest growing segment | Detergents |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Detergents, Chemical Irritants, Osmotic Agents |
Key market players worldwide | B2Gold Corp, LGM Pharma, Troikaa Pharmaceuticals, Mylan, Perrigo Co PLC, Merz Pharma, Medi-Globe |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sclerotherapy market will help companies and investors design strategic landscapes.
Detergents was the largest segment with a revenue share of 41.43% in 2020. Horizon Databook has segmented the Argentina sclerotherapy market based on detergents, chemical irritants, osmotic agents covering the revenue growth of each sub-segment from 2016 to 2027.
Argentina’s weak peso and high standard of aesthetic procedures have made it an attraction for people looking for best quality treatment at a cheaper cost. The Argentinian city of Bueno Ares is a hub for all types of beauty treatment and noninvasive aesthetic procedures including sclerotherapy.
According to NCBI, a recent National Survey of Risk Factors in Argentina stated that 33.1% of the population are overweight and 32.4% are obese indicating low levels of physical activity, and can be attributed to lack of effective public health policies in the country.
According to a study conducted by NCBI, which included 1315 patients from 28 Institutions throughout 5 Argentinian provinces, 112 (8.5%) suffered from varicose veins and chronic venous insufficiency. In a recent international study by Lamontagne on 3,746 medical/surgical patients in intensive care, 98% of them population involved deep vein thrombosis of the lower extremities.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina sclerotherapy market, including forecasts for subscribers. This country databook contains high-level insights into Argentina sclerotherapy market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account